Negative urgency and the dual pathway model of bulimic symptoms: A longitudinal analysis
Sign Up to like & getrecommendations! Published in 2019 at "European Eating Disorders Review"
DOI: 10.1002/erv.2647
Abstract: OBJECTIVE This study extends the dual pathway model (DPM) of bulimic symptoms by considering the bidirectional effects amongst symptoms of depression, dietary restraint, and bulimia. We also assessed the influence of negative urgency, a personality… read more here.
Keywords: depression; urgency; model; bulimic symptoms ... See more keywords
Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition.
Sign Up to like & getrecommendations! Published in 2019 at "Thrombosis research"
DOI: 10.1016/j.thromres.2019.09.033
Abstract: This review provides the rationale for dual pathway inhibition with the combination of low-dose rivaroxaban (2.5 mg twice daily) to attenuate thrombin generation and aspirin (100 mg once daily) to reduce platelet activation. Such therapy has been… read more here.
Keywords: rivaroxaban plus; pathway inhibition; dual pathway;
Hierarchical Regulation of LaMnO3 Dual-Pathway Strategy for Excellent Room-Temperature Organocatalytic Oxidation Performance.
Sign Up to like & getrecommendations! Published in 2022 at "Inorganic chemistry"
DOI: 10.1021/acs.inorgchem.2c00521
Abstract: The performance-enhancing strategy of a single pathway for perovskite has been widely studied. In this work, the dual-pathway strategy of A-site Ce substitution and nitric acid selective dissolution was proposed. The catalytic oxidation performance of… read more here.
Keywords: dual pathway; strategy; pathway; performance ... See more keywords
State-of-the-art-mini review: Dual pathway inhibition to reduce arterial and venous thromboembolism.
Sign Up to like & getrecommendations! Published in 2022 at "Thrombosis and haemostasis"
DOI: 10.1055/a-1778-1083
Abstract: Venous thromboembolism (VTE) and arterial thromboembolism (ATE) are linked by the common mechanism of thrombin generation. Historically these entities have been treated as separate pathophysiologic processes requiring different treatments: VTE, as the formation of fibrin-/coagulation-factor-derived… read more here.
Keywords: pathway inhibition; dual pathway; thromboembolism; venous thromboembolism ... See more keywords
Switching from dual antiplatelet therapy with aspirin plus a P2Y12 inhibitor to dual pathway inhibition with aspirin plus vascular-dose rivaroxaban.
Sign Up to like & getrecommendations! Published in 2023 at "Thrombosis and haemostasis"
DOI: 10.1055/a-2098-6639
Abstract: BACKGROUND To date, there is no data on switching to dual pathway inhibition (DPI) patients who have completed a guideline-recommended dual antiplatelet therapy (DAPT) regimen. OBJECTIVES To assess the feasibility of switching from DAPT to… read more here.
Keywords: switching dual; inhibition; dual pathway; aspirin plus ... See more keywords
Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence.
Sign Up to like & getrecommendations! Published in 2020 at "Thrombosis and haemostasis"
DOI: 10.1055/s-0040-1713376
Abstract: Despite advances in secondary prevention strategies in patients with cardiovascular disease, the residual risk of recurrent atherothrombotic events remains high. Dual-antiplatelet therapy is the standard of care for secondary prevention in patients with acute coronary… read more here.
Keywords: pathway inhibition; patients atherosclerotic; atherosclerotic disease; vascular protection ... See more keywords
Dual Pathway Inhibition with Rivaroxaban and Aspirin Reduces Inflammatory Biomarkers in Atherosclerosis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cardiovascular Pharmacology"
DOI: 10.1097/fjc.0000000000001382
Abstract: Abstract: Dual pathway inhibition (DPI) with low-dose rivaroxaban and aspirin in patients with coronary artery disease (CAD) and/or peripheral artery disease (PAD) reduces the occurrence of cardiovascular (CV) events; however, the underlying mechanisms explaining these… read more here.
Keywords: pathway inhibition; pathway; dual pathway; rivaroxaban aspirin ... See more keywords
Brain Cognition-Inspired Dual-Pathway CNN Architecture for Image Classification.
Sign Up to like & getrecommendations! Published in 2023 at "IEEE transactions on neural networks and learning systems"
DOI: 10.1109/tnnls.2023.3237962
Abstract: Inspired by the global-local information processing mechanism in the human visual system, we propose a novel convolutional neural network (CNN) architecture named cognition-inspired network (CogNet) that consists of a global pathway, a local pathway, and… read more here.
Keywords: cnn architecture; cnn; dual pathway; image ... See more keywords
Metabolic Interventions in Tumor Immunity: Focus on Dual Pathway Inhibitors
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15072043
Abstract: Simple Summary Metabolic reprogramming is one of tumor and immune cells’ most significant metabolic alterations. Moreover, metabolic-related signaling pathways, such as phosphoinositide 3-kinases (PI3Ks), the mammalian target of rapamycin (mTOR), can induce growth, proliferation, and… read more here.
Keywords: metabolic interventions; dual pathway; metabolic reprogramming; pathway inhibitors ... See more keywords
Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances.
Sign Up to like & getrecommendations! Published in 2022 at "Kardiologia polska"
DOI: 10.33963/kp.a2022.0283
Abstract: Atherosclerotic cardiovascular disease (ASCVD), which includes coronary artery disease (CAD), cerebrovascular disease, and peripheral arterial disease (PAD) is associated with significant morbidity, mortality, and healthcare costs. Antiplatelet therapy has long been the mainstay of antithrombotic… read more here.
Keywords: cardiovascular disease; disease; dual pathway; disease recent ... See more keywords